Safety and efficacy of ruxolitinib cream for the treatment of vitiligo: A randomised controlled trial secondary analysis at 3 years
| dc.contributor.author | Harris, John E. | |
| dc.contributor.author | Pandya, Amit G. | |
| dc.contributor.author | Lebwohl, Mark | |
| dc.contributor.author | Hamzavi, Iltefat H. | |
| dc.contributor.author | Grimes, Pearl | |
| dc.contributor.author | Gottlieb, Alice B. | |
| dc.contributor.author | Sofen, Howard L. | |
| dc.contributor.author | Moore, Angela Y. | |
| dc.contributor.author | Wang, Mingyue | |
| dc.contributor.author | Kornacki, Deanna | |
| dc.contributor.author | Butler, Kathleen | |
| dc.contributor.author | Rosmarin, David | |
| dc.contributor.department | Dermatology, School of Medicine | |
| dc.date.accessioned | 2025-01-27T11:51:31Z | |
| dc.date.available | 2025-01-27T11:51:31Z | |
| dc.date.issued | 2024-08-07 | |
| dc.eprint.version | Final published version | |
| dc.identifier.citation | Harris JE, Pandya AG, Lebwohl M, et al. Safety and efficacy of ruxolitinib cream for the treatment of vitiligo: A randomised controlled trial secondary analysis at 3 years. Skin Health Dis. 2024;4(6):e404. Published 2024 Aug 7. doi:10.1002/ski2.404 | |
| dc.identifier.uri | https://hdl.handle.net/1805/45482 | |
| dc.language.iso | en_US | |
| dc.publisher | Oxford University Press | |
| dc.relation.isversionof | 10.1002/ski2.404 | |
| dc.relation.journal | Skin Health and Disease | |
| dc.rights | Attribution 4.0 International | en |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
| dc.source | PMC | |
| dc.subject | Vitiligo | |
| dc.subject | Skin depigmentation | |
| dc.subject | Ruxolitinib cream | |
| dc.title | Safety and efficacy of ruxolitinib cream for the treatment of vitiligo: A randomised controlled trial secondary analysis at 3 years | |
| dc.type | Article |